Keyphrases
Dendritic Cell Vaccine
100%
Cancer Immunotherapy
100%
MicroRNA Signature
100%
Dendritic Cells
100%
MicroRNA
71%
Cell Phenotype
28%
Cell-based
28%
CD86
14%
CD80
14%
Quantitative PCR
14%
Northern Blotting
14%
Cancer Vaccine
14%
Secreted Cytokine
14%
Tumor Antigen
14%
CCR7
14%
Microarray
14%
Clinical Outcome Prediction
14%
Activated Dendritic Cells
14%
Quantitative Evaluation
14%
Hsa-miR-146a
14%
Immunogenicity
14%
Differentially Expressed
14%
HLA-DR
14%
CD83
14%
Interleukin-12p70
14%
MiR-29a
14%
MiR-125b
14%
Differential Expression
14%
Immature Dendritic Cells
14%
Functional State
14%
Surface Markers
14%
Vaccine Potency
14%
MicroRNA-155 (miR-155)
14%
Pharmacology, Toxicology and Pharmaceutical Science
Dendritic Cell Vaccine
100%
microRNA
100%
Malignant Neoplasm
100%
Immunotherapy
100%
Interleukin 12p70
16%
Tumor Vaccine
16%
microRNA 29a
16%
Immunogenicity
16%
microRNA 146a
16%
Vaccine
16%
microRNA 155
16%
Biological Marker
16%
Tumor Antigen
16%
Cytokine
16%
Medicine and Dentistry
Cancer Immunotherapy
100%
Dendritic Cell
100%
microRNA
100%
Dendritic Cell Vaccine
100%
Tumor Antigen
9%
Biological Marker
9%
Real Time Polymerase Chain Reaction
9%
Northern Blotting
9%
Tumor Vaccine
9%
Cell Therapy
9%
Cytokine
9%
Immunology and Microbiology
Dendritic Cell Vaccine
100%
Cancer Immunotherapy
100%
Dendritic Cell
100%
Real Time Polymerase Chain Reaction
9%
Tumor Vaccine
9%
HLA-DR
9%
Northern Blotting
9%
Tumor Antigen
9%
Cytokine
9%
Vaccine Efficacy
9%
Immunogenicity
9%
CD80
9%
CD86
9%
CD83
9%